About Valens Molecules
Valens Molecules is a Healthcare company based in Hyderabad (India). Valens Molecules is engaged in manufacturing APIs and specialty chemicals. It operates on a B2B2C and Reseller / Distribution model in Healthcare and Chemicals & Materials sectors. The company has 178 employees. Its Indian entity Valens Molecules Private Limited reported revenue of ₹100 Cr. Valens Molecules offers products and services including Active Pharma Ingredients, Formulation Intermediates, and Specialty Chemicals. Its focus areas include Pharmaceuticals, Active Pharmaceutical Ingredients, Chemicals and Specialty Chemicals.
Company details
Valens Molecules is recognized as a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and specialty chemicals, serving pharmaceutical, animal health, and industrial sectors. The company is partnered with market leaders across 24 countries on 5 continents. High-quality products are delivered through state-of-the-art, certified facilities adhering to international standards such as USFDA, WHO GMP, and ISO certifications. Customized manufacturing solutions are provided via multipurpose facilities, ensuring modular and innovative processes. Long-term partnerships are fostered for process development and fulfillment, positioning the company as a trusted global supplier.
- Headquarters Hyderabad, India
- Employees 178
- SectorsHealthcareChemicals & Materials
- Phone•••• ••••
- Website valensmolecules.com
- Legal Name Valens Molecules Private Limited
- Date of Incorporation 02 Nov, 1994
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹100 Cr
FY 2025 · 0% YoY
- Net Profit₹11.17 Cr
FY 2025 · 11% margin
- EBITDA₹23.98 Cr
FY 2025 · 24% margin
- Employee Count178
Associated legal entities of Valens Molecules
Valens Molecules operates through Valens Molecules Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Valens Molecules Private Limited CIN U24100TG1994PTC018680 | Active | 02 Nov 1994 | Hyderabad, Telangana | ₹100 Cr | 178 | 7 | View details |
Products & Services of Valens Molecules
Valens Molecules offers a comprehensive portfolio of products and services, including Active Pharma Ingredients, Formulation Intermediates, and Specialty Chemicals.
Active ingredients are manufactured for pharmaceutical applications globally.
Intermediates are produced for pharmaceutical formulation processes worldwide.
Specialty chemicals are supplied for various industrial applications.
Board of directors of Valens Molecules Private Limited (Valens Molecules)
Valens Molecules Private Limited is the primary company behind Valens Molecules. The board of Valens Molecules Private Limited currently have 6 directors; the longest-serving is Padmasree Cherukuri, appointed in 1994. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Padmasree Cherukuri DIN 00771835 | Whole-time director | 02 Nov 1994 | 31 yrs 11 mo | Valens Molecules Private Limited |
| Cherukuri Surya Ratna Prasad DIN 00184433 | Managing Director | 02 May 1995 | 31 yrs 5 mo | Valens Molecules Private Limited |
| Mulukutla Sambasiva Sastry DIN 00184641 | Director | 28 Aug 2001 | 25 yrs 1 mo | Valens Molecules Private Limited |
| Cherukuri Poshya DIN 00771807 | Whole-time director | 26 Aug 2006 | 20 yrs 2 mo | Valens Molecules Private Limited |
| Rahul Yalamanchili DIN 05157187 | Whole-time director | 07 Jan 2013 | 13 yrs 9 mo | Valens Molecules Private Limited |
| Cherukuri Ranga Prakash DIN 03263229 | Whole-time director | 24 Oct 2014 | 12 yrs | Valens Molecules Private Limited |
Financials of Valens Molecules
Figures of Valens Molecules Private Limited, the primary company behind Valens Molecules, for FY 2025. Revenue was ₹100 Cr (0% year on year). Net profit was ₹11.17 Cr (11% margin). EBITDA was ₹23.98 Cr (24% margin). Revenue has grown at a compounded annual rate of +1% over three years and +13% over five years.
- ₹100 CrRevenue · FY 2025 · 0% YoY
- ₹11.17 CrNet profit · 11% margin
- ₹23.98 CrEBITDA · 24% margin
- ₹10.88 CrPaid-up capital
- 178Employees (provident fund records)
- +1%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Valens Molecules Private Limited are on its company page.
Detailed financial statements for Valens Molecules
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Valens Molecules
Valens Molecules is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Valens Molecules has 178 employees.
The primary company behind Valens Molecules, Valens Molecules Private Limited, reported revenue of ₹100 Cr for FY 2025, down 0% year on year.
Valens Molecules is recognized as a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and specialty chemicals, serving pharmaceutical, animal health, and industrial sectors. The company is partnered with market leaders across 24 countries on 5 continents. High-quality products are delivered through state-of-the-art, certified facilities adhering to international standards such as USFDA, WHO GMP, and ISO certifications. Customized manufacturing solutions are provided via multipurpose facilities, ensuring modular and innovative processes. Long-term partnerships are fostered for process development and fulfillment, positioning the company as a trusted global supplier.
Valens Molecules offers Active Pharma Ingredients, Formulation Intermediates, and Specialty Chemicals.
Valens Molecules operates through Valens Molecules Private Limited.
The legal entities of Valens Molecules currently have 7 directors, including Cherukuri Poshya, Padmasree Cherukuri, Cherukuri Ranga Prakash and others.